Reversal of Hyperglycemia by Subcutaneous Islet Engraftment Using an Atelocollagen Sponge as a Scaffold

Reversal of Hyperglycemia by Subcutaneous Islet Engraftment Using an Atelocollagen Sponge as a Scaffold

Type 1 diabetes mellitus (T1DM) affects 8.4 million people worldwide, with patients primarily relying on exogenous insulin injections to maintain blood glucose levels. Islet transplantation via the portal vein has allowed for the direct internal release of insulin by glucose-sensitive islets. Howeve...

Full description

Bibliographic Details
Main Authors: Yumeng Wu, Tatsuya Yano, Takayuki Enomoto, Atena Endo, Seiji Okada, Kimi Araki, Nobuaki Shiraki, Shoen Kume
Format: Article
Language:English
Published: SAGE Publishing 2024-09-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/09636897241277980

Internet

https://doi.org/10.1177/09636897241277980

Similar Items